GLOBEALERT
Sign in
SCI & TECH● ELEVATED1h ago · Oct 23, 2026, 5:27 PM

A vaccine designed for each patient achieved a 58% reduction in the risk of relapse in high-risk melanoma

Clarín · global

Cada dosis se construye a partir de la huella única del tumor del paciente.Los datos del ensayo global son considerados un punto de inflexión en la historia oncológica.

Read at Clarín Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Sci & Tech

SCI & TECH11m agoPresident: Speed limits for Starlink and Starshield remain in effectUkrinform [en]SCI & TECH1h agoTikTok's U.S. entity seeking four gigawatts of compute power -- CNBCSeeking Alpha TechSCI & TECH2h agoZelenskyy tells ABC News Starlink network still isn't fully workingABC NewsSCI & TECH2h agoA year ahead of the ‘wrecking ball’: Scientists find new clue to predict when El Niño will strikeEuroNews [en]